Core Viewpoint - The company plans to use up to RMB 100 million of idle raised funds to temporarily supplement working capital, ensuring that it will only be used for business expansion and daily operations related to its main business, without affecting the normal investment plan of the raised funds [1][4][5] Summary by Sections 1. Basic Situation of Raised Funds - The company issued 147,555,000 shares at a price of RMB 1.00 per share, raising a net amount of RMB 1,854,736,926.64 after deducting various fees totaling RMB 178,570,973.36 [1][2] 2. Previous Use of Idle Funds - The company previously used up to RMB 150 million of idle raised funds to temporarily supplement working capital, which was returned by August 6, 2025 [2][3] 3. Investment Projects of Raised Funds - The total investment amount for the projects was RMB 200,181 million, with an adjusted planned use of raised funds amounting to RMB 185,473.69 million [3] 4. Plan for Temporary Use of Idle Funds - The company intends to use idle funds through a special account for a period not exceeding 12 months, ensuring that it will not affect the investment projects [4][5] 5. Review Procedures - The board and supervisory committee approved the use of idle funds, confirming compliance with relevant regulations and ensuring no impact on the investment projects [5][6] 6. Special Opinions - The supervisory committee and the underwriting institution agree that the temporary use of idle funds will enhance efficiency and reduce financial costs, aligning with the interests of the company and shareholders [5][6]

中国国际金融股份有限公司 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于核准多氟多新材料股份有限公司非 公开发行股票的批复》（证监许可[2022]2962 号）的核准，公司以 16.35 元/股向 特 定 对 象 发 行 人 民 币 普 通 股 （ A 股 ） 122,324,159 股 ， 募 集 资 金 总 额 为 为 1,988,036,522.71 元。 《深圳证券 关于多氟多新材料股份有限公司 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板 《深圳证券交易所上市公司自律监管指引第 13 号——保荐业 使用部分闲置募集资金暂时补充流动资金的核查意见 上市公司规范运作》 务》等相关法律、法规和规范性文件的规定，对多氟多使用部分闲置募集资金暂 时补充流动资金的事项进行了审慎核查，具体情况如下： 《上市公司募集资金监管规则》 中国国际金融股份有限公司（以下简称"中金公司"、"保荐机构"）作为多 氟多新材料股份有限公司（以下简称"多氟多"、"公司"）的持续督导机构，根 据《证券发行上市保荐业务管理办法》 上述募集资金到位情况业经大华会计师事务所（特殊普通合伙）于 202 ...

Core Viewpoint - The company, Zhenray Technology, has shown a positive stock performance with a closing price of 56.37 yuan, up 4.54% as of August 6, 2025, indicating investor confidence in its growth potential [1] Group 1: Company Performance - Zhenray Technology's stock price increased by 4.54% to 56.37 yuan, with a trading volume of 95,400 shares and a total transaction amount of 532 million yuan on August 6, 2025 [1] - The company has reported a significant increase in its order backlog, including verbal orders, indicating a strong growth trajectory in its traditional remote sensing satellite sales [2] Group 2: Financial Management - The company has announced the cancellation of certain fundraising special accounts and will permanently supplement its working capital with the remaining funds from its initial public offering, which raised approximately 1.69 billion yuan [4][5] - The company has also terminated the regulatory agreements associated with the canceled fundraising accounts, streamlining its financial management processes [5] Group 3: Market Activity - On August 6, 2025, the main funds experienced a net outflow of 27.42 million yuan, accounting for 5.15% of the total transaction amount, while retail investors saw a net inflow of 11.99 million yuan, representing 2.25% of the total [3][6]

Group 1 - The core viewpoint of the article is that CITIC Securities has conducted a thorough review of Shennong Industry Co., Ltd.'s temporary use of idle raised funds to supplement working capital, ensuring compliance with relevant regulations and that it will not affect the company's investment plans [1][6] Group 2 - The company raised a total of 3 billion yuan by issuing 30 million convertible bonds at a face value of 100 yuan each, as approved by the China Securities Regulatory Commission [1][2] - The company has established a special account for the management and use of the raised funds, in accordance with regulatory requirements [2] - The company previously approved the temporary use of up to 1 billion yuan of idle raised funds to supplement working capital, with a repayment deadline of 12 months from the board's approval date [2][3] Group 3 - The company has cumulatively used 1.81892 billion yuan of the raised funds for various projects, with a total investment amount of 5.98567 billion yuan [4][5] - The company plans to use up to 800 million yuan of idle raised funds temporarily to supplement working capital, ensuring that it does not impact the progress of investment projects [5][6] Group 4 - The board and supervisory committee of the company have approved the use of idle raised funds, confirming that the decision-making process complies with relevant regulations [6] - The supervisory committee believes that the temporary use of idle funds will enhance the efficiency of fund utilization and reduce financial costs without harming shareholder interests [6]

Core Viewpoint - The company intends to change part of the raised funds to permanently supplement its working capital, which is deemed a reasonable decision based on current industry conditions and business development needs [3][6]. Fundraising Basic Situation - In July 2017, the company raised a net amount of approximately 590.16 million yuan from a non-public offering of 45,511,698 shares, after deducting issuance costs [1]. - The funds were verified by an accounting firm and a report was issued confirming the amount [1]. Fund Usage Status - As of June 30, 2025, the total balance of the raised funds is approximately 363.39 million yuan, with specific balances in various bank accounts and financial products [2]. - The company has utilized approximately 282.36 million yuan of the raised funds for investment projects [2]. Reasons for Permanent Supplementation of Working Capital - The company has not identified suitable investment projects for part of the raised funds, totaling approximately 110.72 million yuan, and aims to enhance cash flow and operational capacity by reallocating these funds [3][4]. Impact of Fund Reallocation - The decision to permanently supplement working capital is expected to improve fund utilization efficiency and will not adversely affect the company's normal operations or existing investment projects [3][6]. Related Review Procedures - The board of directors and the supervisory board have approved the proposal to reallocate the funds, which will be submitted for shareholder approval [4][6].

Core Viewpoint - The company is utilizing part of the idle funds raised from a non-public offering to temporarily supplement its working capital, which is deemed necessary for operational efficiency and financial management [1][5][6]. Summary by Sections 1. Non-Public Offering Fund Details - In 2017, the company raised a total of RMB 1,306,108,798.84 through a non-public offering of 74,720,183 shares at RMB 17.48 per share, with net proceeds amounting to RMB 1,288,808,798.84 after deducting issuance costs [1]. - As of June 30, 2025, the company has utilized RMB 910,351,700 for various projects, including RMB 224,940,400 for self-funded projects [2][3]. 2. Fund Utilization and Remaining Balance - The company has invested in several projects, with the following actual investment amounts: - Chemical Preparation International Industrialization Project: RMB 545,134,000 - Lianhua Qingwen Capsule International Registration Project: RMB 206,108,800 - Lianhua Qingwen Series Product Capacity Enhancement Project: RMB 254,866,000 - Supplementing Working Capital: RMB 300,000,000 - Total: RMB 1,306,108,800 [3][4]. - As of June 30, 2025, the remaining balance of the non-public offering funds is RMB 50,706,684.42 [4][5]. 3. Temporary Working Capital Supplement - The company plans to use up to RMB 150,000,000 of idle funds to temporarily supplement working capital, with a usage period not exceeding 12 months [5][6]. - The decision is based on the expectation that approximately RMB 150,000,000 will be idle in the Chemical Preparation International Industrialization Project over the next 12 months, aiming to enhance fund utilization efficiency and reduce financial costs [5][6]. 4. Approval and Compliance - The proposal to use idle funds for working capital has been approved by the company's board and is compliant with relevant regulations, ensuring that it does not affect the ongoing projects or shareholder interests [6][7].

Summary of Key Points Core Viewpoint - The company intends to temporarily use part of its idle raised funds to supplement working capital, ensuring that this does not affect the implementation of its fundraising investment projects [1][4][6]. Group 1: Fundraising Overview - The company raised a total of RMB 894,999,954.16, with a net amount of RMB 875,792,998.29 after deducting related expenses [1][2]. - The funds were raised through the issuance of 96,030,038 shares at a price of RMB 9.32 per share, approved by the China Securities Regulatory Commission on June 26, 2023 [1]. Group 2: Fund Management and Usage - The company has established a fundraising supervision account and signed a tripartite/four-party supervision agreement with the sponsor and relevant banks [2]. - As of July 1, 2025, the company has used RMB 69,363.46 million of the raised funds, leaving RMB 18,985.96 million (including interest and net cash management income) unutilized [2]. Group 3: Temporary Fund Usage - The company plans to use up to RMB 17,500 million of idle funds to temporarily supplement working capital, with a usage period of up to 12 months from the board's approval [4][5]. - This temporary use of funds is expected to save approximately RMB 5.25 million in financial costs based on the current one-year loan market quotation rate of 3% [4]. Group 4: Compliance and Approval - The board and supervisory committee have approved the use of idle funds, confirming that it will not affect the normal progress of fundraising investment projects [6]. - The sponsor has verified that the company's actions comply with relevant regulations and do not change the intended use of the raised funds [6].

Core Viewpoint - The company intends to temporarily use part of its idle raised funds to supplement working capital, ensuring that this does not affect the normal progress of its fundraising investment projects [6][9]. Group 1: Fundraising Overview - The company was approved to publicly issue 70.6 million shares at a price of RMB 13.39 per share, raising a total of RMB 945.334 million, with a net amount of RMB 843.209 million after deducting issuance costs [2][3]. - As of the date of the verification opinion, the remaining balance of the raised funds is RMB 192.519 million, including oversubscription funds [6]. Group 2: Fund Utilization - The company has used RMB 496.663 million of the raised funds for third-party medical device logistics construction projects [4]. - The company plans to use up to RMB 92.75 million of idle raised funds temporarily to supplement working capital, with a usage period not exceeding 12 months [7][9]. Group 3: Approval and Oversight - The board of directors and the supervisory board have approved the use of idle funds, ensuring compliance with relevant regulations [9][10]. - The company will open a special account at a bank for the management of these funds and sign a tripartite supervision agreement to oversee the storage and usage of the raised funds [8]. Group 4: Financial Efficiency - By utilizing the idle funds, the company expects to save approximately RMB 2.78 million in financial costs based on the current loan market rate of 3.00% [8].

Summary of Key Points Core Viewpoint - The company intends to use part of the temporarily idle raised funds to supplement its working capital, which is deemed necessary for improving fund utilization efficiency and reducing financial costs [2][6][9]. Group 1: Fundraising Overview - The company issued 13,794,971 convertible bonds at a face value of 100 RMB each, raising a total of 1,379,497,100 RMB, with a net amount of 1,357,031,302.96 RMB after deducting underwriting fees [2][3]. - The funds are stored in a dedicated account as per the regulatory requirements, and a tripartite supervision agreement has been signed [3][4]. Group 2: Fund Utilization Plan - Originally, the raised funds were planned for specific projects, including the development of natural gas resources in the Shilou West Block, with a total investment of 137,949.71 million RMB [3][4]. - The company has proposed to use up to 40,000 million RMB of temporarily idle funds to supplement working capital, with a usage period not exceeding 12 months [5][6]. Group 3: Financial Efficiency - The company operates in a capital-intensive industry, necessitating the use of various financing sources, including loans, to support its operations [6][7]. - By utilizing idle funds for working capital, the company expects to save approximately 3.00% in financial costs based on current loan market rates [6][7]. Group 4: Internal Decision-Making Process - The board of directors and the supervisory board have approved the use of idle funds, confirming that the necessary internal procedures were followed [7][9]. - The funds can be used in a rolling manner within the approved limits and timeframe, ensuring that they will be returned to the dedicated account as needed [7][9].

特此公告 浙江省建设投资集团股份有限公司 董事会 二零二五年六月十六日 在授权额度和期限内，公司实际使用暂时闲置的募集资金共计人民币 30,000 万元暂时用 于补充流动资金。公司对这部分募集资金进行了合理安排与使用，未影响募集资金投资项目的 正常进行。截至 2025 年 6 月 16 日，公司已将上述暂时补充流动资金的募集资金共计人民币 集资金的归还情况通知了公司的保荐机构及保荐代表人。 证券代码：002761 证券简称：浙江建投 公告编号：2025-063 债券代码：127102 债券简称：浙建转债 浙江省建设投资集团股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江省建设投资集团股份有限公司（以下简称"公司"）于 2024 年 6 月 17 日召开了第 四届董事会第三十九次会议及第四届监事会第二十六次会议，审议通过了《关于使用部分闲置 募集资金暂时补充流动资金的议案》，同意公司在保证募集资金投资项目建设的资金需求、保 证募集资金投资项目正常进行的前提下，拟使用发行可转债募集的总额不超过 30,000 万元人 民币的闲置募集资金暂时用于补充 ...